文献速递心律失常

无结构性心脏病患者室性早搏与房颤及卒中风险

Premature ventricular complexes and risk of atrial fibrillation and stroke in patients without structural heart disease.
PubMed 文献 · Heart · 2025-12-11

该回顾性观察性队列研究纳入瑞典斯德哥尔摩三家医院诊断室性早搏且无结构性心脏病、无房颤或卒中史的患者751例,并按1:4匹配一般人群对照3041例。中位随访5.2年,未调整分析显示室早组房颤风险较高(HR 2.08,95%CI 1.35–3.20,p=0.0009),但经逆概率加权调整后房颤(HR 1.44,95%CI 0.88–2.37)与卒中(HR 1.32,95%CI 0.81–2.14)风险均无显著差异。

要点

  • 无结构性心脏病的室早患者,调整混杂后房颤与卒中风险未显著增加。
  • 未调整分析中室早与房颤相关,提示室早可能是房颤的临床标志。
  • 对无结构性心脏病的室早患者,需关注房颤筛查而非直接归因卒中风险。

核心结论

  • 在无结构性心脏病的室早患者中,调整已知混杂因素后,房颤和卒中风险与一般人群对照相比无显著增加。
  • 未调整队列中室早与房颤相关,提示室早可能是房颤的临床标志。

研究设计与样本

  • 回顾性观察性队列研究,纳入瑞典斯德哥尔摩三家医院诊断室早的患者751例,并按1:4匹配一般人群对照3041例。
  • 入选患者无心脏病史、负荷试验和超声心动图正常、无既往房颤或卒中诊断。
  • 采用逆概率加权(IPW)控制基线特征差异,中位随访5.2年。

主要发现

  • 中位年龄59岁,2239例(59%)为女性。
  • 未调整分析中,室早组房颤风险高于对照组(HR 2.08,95%CI 1.35–3.20,p=0.0009)。
  • 经IPW调整后,室早组与对照组房颤风险无显著差异(HR 1.44,95%CI 0.88–2.37)。
  • 经IPW调整后,室早组与对照组卒中风险无显著差异(HR 1.32,95%CI 0.81–2.14)。

临床怎么用

  • 对于无结构性心脏病的室早患者,不应仅凭室早诊断即视为房颤或卒中的高风险人群。
  • 未调整分析中室早与房颤相关,提示对此类患者可考虑关注房颤的临床筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Prior studies have suggested that patients with premature ventricular complexes (PVCs) may have an increased risk for atrial fibrillation (AF) and stroke. It is unclear whether frequent PVCs are linked to an increased risk of AF and stroke in patients where structural heart disease (SHD) has been excluded. We aimed to study if PVCs increase the risk of AF or stroke in patients without SHD. METHODS: In this retrospective observational cohort study, we included patients who received a PVC diagnosis at three major hospitals in Stockholm, Sweden. The patients had no history of heart disease, normal results at stress test and echocardiography, and no previous diagnosis of AF or stroke. For each case, four matched controls were obtained from the general population. We used inverse probability weighting (IPW) to control for differences in baseline characteristics. RESULTS: A total of 751 PVC patients and 3041 controls were included. The median age was 59 years, and 2239 (59%) were women. The median follow-up time was 5.2 years. There was a higher risk of AF among patients in the PVC group compared with the control group in the unadjusted analysis (HR 2.08, 95% CI 1.35 to 3.20, p=0.0009). After IPW, there was no significant difference in the risk of AF (HR 1.44, 95% CI 0.88 to 2.37) or stroke (HR 1.32, 95% CI 0.81 to 2.14) between the PVC group and the control group. CONCLUSION: In patients with PVCs but without SHD, there was no increased risk of AF or stroke compared with controls from the general population after adjusting for known confounders. However, PVCs were associated with AF in the crude cohort, suggesting that PVCs may be a clinical marker for AF.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Bouleau, Glaser, Jonsson, et al. Premature ventricular complexes and risk of atrial fibrillation and stroke in patients without structural heart disease. Heart. 2025. PMID: 40550639. doi:10.1136/heartjnl-2024-325322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。